Research & Education

Study shows SBRT for Stage I NSCLC safe and effective

Data collected from 582 non-small cell lung cancer patients who underwent stereotactic body radiotherapy

DENVER – Stereotactic body radiotherapy (SBRT) is considered the treatment of choice for early-stage non–small-cell lung cancer (NSCLC) if patients

Researchers use immunocytochemistry to determine ALK status

Tests continue trend in personalize medicine for lung cancer patients

DENVER – Personalized medicine in lung cancer relies on the identification and characterization of cancer biomarkers and the availability of accura